Journals / Respiratory Case Reports / 2019 / Cilt: 8 - Sayı: 2

Sistemik Lupus Eritematozusta İnterstisyel Akciğer Hastalığı

Interstitial Lung Disease in Systemic Lupus Erythematosus

Pages
40–43
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Bir olguda SLE’nin ilk bulgusu İAH idi, diğer olguda SLE tanısından sonra İAH görüldü.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nedeni bilinen interstisiyel akciğer hastalıklarının (İAH) etyolojilerinden birisi de bağ dokusu hastalıkları (BDH)'dır.
📊
Key Findings & Data:Nedeni bilinen İAH’ya yol açana BDH arasında, sistemik skleroz, romatoid artrit, miks bağ dokusu hastalıkları ve Sjögren sendromu sıklıkla bulunmaktadır.
💡
Conclusion & Impact:Bir olguda SLE’nin ilk bulgusu İAH idi, diğer olguda SLE tanısından sonra İAH görüldü.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Nedeni bilinen interstisiyel akciğer hastalıklarının (İAH) etyolojilerinden birisi de bağ dokusu hastalıkları (BDH)'dır. Nedeni bilinen İAH’ya yol açana BDH arasında, sistemik skleroz, romatoid artrit, miks bağ dokusu hastalıkları ve Sjögren sendromu sıklıkla bulunmaktadır. Ancak sistemik lupus eritematozus (SLE) hastalarında bu durum nadiren görülür. SLE’de İAH tanısı koymak zordur. Hava yolu hastalıkları, pulmoner infeksiyon ve vasküler anormallikler gibi diğer pulmoner tutulumlar öncelikle ekarte edilmelidir. SLE de ve diğer BDH olan İAH hastalarının tedavisinde kortikosteroidler ve diğer immünsüpressif ilaçlar kullanılır. Burada İAH olan iki SLE olgusu sunulmaktadır. Bir olguda SLE’nin ilk bulgusu İAH idi, diğer olguda SLE tanısından sonra İAH görüldü.

Özet

Connective tissue disease (CTD) is one of the etiologies of known-cause interstitial lung disease (ILD) that is frequently found with systemic sclerosis, rheumatoid arthritis, mixed-CTD and Sjӧgren syndrome, but which occurs rarely in systemic lupus erythematosus (SLE) patients. A diagnosis of ILD in SLE can be challenging, as the physician should first exclude other pulmonary involvements, including airway disorders, pulmonary infection and vascular abnormality. The management of ILD in SLE and other CTDs patients includes corticosteroid and other immunosuppressive medications. Here we report on two ILD in SLE cases: in one case, ILD was the first sign of SLE; and in another, ILD appeared after the diagnosis of SLE had been established.

🔖

Cite This Article

AMANDA, G., FATHANA, P. B., SUTOYO, D. K. (2019). Sistemik Lupus Eritematozusta İnterstisyel Akciğer Hastalığı. Respiratory Case Reports, Cilt: 8 - Sayı: 2, 40–43. https://ajindex.com/articles/299385

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Papiris SA, Manali ED, Kolilekas L, Kagouridis K, Maniati M, Borie R, et al. Investigation of lung involvement in connective tissue disorders. Respiration 2015; 90:2-24. [CrossRef] 2. Mittoo S, Fell CD. Pulmonary manifestations of systemic lupus erythematosus. Semin Respir Crit Care Med 2014; 35:249-54. [CrossRef] 3. Fischer A, Brown KK. Interstitial lung disease in undifferentiated forms of connective tissue disease. Arthritis Care Res (Hoboken) 2015; 67:4-11. [CrossRef] 4. Vij R, Strek ME. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest 2013; 143:814-24. [CrossRef] 5. Castelino FV, Varga J. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther 2010; 12:213. [CrossRef] 6. Fong W, Yoong J. Interstitial lung disease and rheumatoid arthritis: a review. Proceed Singapore Healthcare 2015; 24:35-41. [CrossRef] 7. Demoruelle MK, Mittoo S, Solomon JJ. Connective tissue disease-related interstitial lung disease. Best Pract Res Clin Rheumatol 2016; 30:39-52. [CrossRef] 8. Antin-Ozerkis D, Rubinowitz A, Evans J, Homer RJ, Matthay RA. Interstitial lung disease in the connective tissue diseases. Clin Chest Med 2012; 33:123-49. [CrossRef] 9. Aparicio IJ, Lee JS. Connective tissue disease-associated interstitial lung diseases: unresolved issues. Semin Respir Crit Care Med 2016; 37:468-76. [CrossRef] 10. Henry TS, Little BP, Veeraraghavan S, Bhalla S, Elicker BM. The spectrum of interstitial lung disease in connective tissue disease. J Thorac Imaging 2016; 31:65-77. [CrossRef] 11. Lauretis A, Veeraraghavan S, Renzoni E. Connective tissue disease-associated interstitial lung disease: How does it differ from IPF? How should the clinical approach differ? Chronic Respiratory Disease 2011; 8:53-82. [CrossRef] 12. Lee JS, Fischer A. Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease. Expert Rev Clin Immunol 2016; 12:509-20. [CrossRef] 13. Fischer A, du Bois R. Interstitial lung disease in connective tissue disorders. Lancet 2012; 380:689-98. [CrossRef] 14. Fischer A, Brown KK, Du Bois RM, Frankel SK, Cosgrove GP, Fernandez-Perez ER, et al. Mycophenolate mofetil improves lung function in connective tissue diseaseassociated interstitial lung disease. J Rheumatol 2013; 40(5):640-6. [CrossRef]